New Leaders at FDA


Statement of CSPI Executive Director Michael F. Jacobson

March 14, 2009

Dr. Margaret Hamburg has the experience and public-health focus that makes her a terrific choice for commissioner of the Food and Drug Administration. She has been forward thinking in her approach both to medical and food security issues—a quality that should enable her to return the FDA to its role as a trusted, effective regulatory agency.

Dr. Joshua Sharfstein has not only the knowledge, but also the experience on Capitol Hill and as the health commissioner of a major city, to be an excellent deputy. His innovative public health leadership in Baltimore has had nationwide impact, such as when he challenged the prevailing wisdom on the use and labeling of cough syrup in infants. As health commissioner he helped phase artificial trans fat out of the city's restaurant food—a job that the FDA should complete by getting rid of partially hydrogenated oil from the food supply altogether.

While most past commissioners have focused primarily on the drug side of FDA, Drs. Hamburg and Sharfstein both are well aware the FDA also regulates foods. They will have additional resources and, I hope, new statutory authorities to improve on

FDA’s dismal record in the area of food safety and nutrition.

This new team should give fresh consideration of whether the agency itself needs to be restructured with the food regulatory functions being spun off as an independent agency.

 

Get Updates Via Email

Journalists can receive CSPI news releases via email.
Not a journalist?

Sign Up for Email Now

NAH

NAH

Subscribe Now

Subscribe Now »

Subscribe Today and Save!

In Recent Issues


Cover Story: Tip of the Iceberg: Most people With Prediabetes Don't Know It


Special Feature: Food Poisoning


Brand-Name Rating: Freekeh


NAH
Subscribe Now

Request permission to reuse content

The use of information from this site for commercial purposes is strictly prohibited without written permission from CSPI.

BBB
Guidestar